Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 7732840)

Published in Adv Prostaglandin Thromboxane Leukot Res on January 01, 1995

Authors

D Pratico1, J A Lawson, G A Fitzgerald

Author Affiliations

1: Department of Medicine and Experimental Therapeutics University College, Dublin.

Articles by these authors

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A (1999) 4.16

Acute admissions to medical beds. J R Coll Gen Pract (1972) 3.80

Are Frozen Foods a Public Health Problem? Am J Public Health Nations Health (1947) 3.44

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13

Effects of vitamin E on lipid peroxidation in healthy persons. JAMA (2001) 2.58

The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48

No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol (2001) 2.28

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13

Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest (1997) 1.90

Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J (1998) 1.89

Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol (1998) 1.82

Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest (2000) 1.78

Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol (1993) 1.76

Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation (1996) 1.74

Occupational asthma in newly employed workers in intensive swine confinement facilities. Eur Respir J (2004) 1.63

Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1993) 1.60

Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest (1999) 1.55

Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54

Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J (1991) 1.54

Quality of life after infrainguinal bypass grafting surgery. Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group. J Vasc Surg (1999) 1.49

Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48

Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine. Proc Natl Acad Sci U S A (1999) 1.45

Effects of celecoxib on major prostaglandins in asthma. Clin Exp Allergy (2010) 1.45

IPF2alpha-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci U S A (1998) 1.43

Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42

8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation (1997) 1.41

Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther (1995) 1.38

Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest (1997) 1.38

11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc Natl Acad Sci U S A (1986) 1.35

Paracetemol poisoning--a brief report. Ir Med J (1977) 1.32

The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. J Pharmacol Exp Ther (1997) 1.31

Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo: evidence for a postmitochondrial processing of caspase-8. Toxicol Sci (2000) 1.30

The isoprostanes in biology and medicine. Trends Endocrinol Metab (2001) 1.29

Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha. J Biol Chem (1995) 1.28

Validation of a new quality of life measure for children with epilepsy. Epilepsia (2000) 1.25

Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation (1997) 1.23

Glutathione peroxidase-deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress. Hepatology (1999) 1.23

Nomenclature of isoprostanes: a proposal. Prostaglandins (1997) 1.17

Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc Natl Acad Sci U S A (1990) 1.17

Circadian rhythm of baroreflex reactivity and adrenergic vascular response. Cardiovasc Res (1980) 1.15

Sanitation and Quality Control in the Fishery Industries. Am J Public Health Nations Health (1937) 1.15

Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways. J Biol Chem (1998) 1.14

Calcium-induced release from platelet membranes of fatty acids that modulate soluble guanylate cyclase. J Pharmacol Exp Ther (1983) 1.13

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med (1998) 1.12

Increased excretion of leukotriene E4 during aspirin-induced asthma. J Lab Clin Med (1992) 1.11

Randomised controlled trial comparing sapheno-femoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anaesthesia: one year results. Eur J Vasc Endovasc Surg (2010) 1.11

Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J (Clin Res Ed) (1986) 1.10

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. Am Rev Respir Dis (1990) 1.08

Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. Mol Pharmacol (1993) 1.07

Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens (2000) 1.07

Assessment of endotoxin levels in the home and current asthma and wheeze in school-age children. Indoor Air (2008) 1.05

Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut (1994) 1.05

Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1989) 1.04

Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man. Eur J Clin Invest (1980) 1.04

The health-related quality of life of childhood epilepsy syndromes. J Paediatr Child Health (2003) 1.02

Effects of nicotinic acid on insulin sensitivity and blood pressure in healthy subjects. J Hum Hypertens (2000) 1.02

Circadian variation in adrenergic responses in asthmatic subjects. Clin Sci (Lond) (1982) 1.00

Measurement of renal and non-renal eicosanoid synthesis. Am J Med (1986) 0.99

The health-related quality of life of children with refractory epilepsy: a comparison of those with and without intellectual disability. Epilepsia (2001) 0.99

The Royal College of General Practitioners: its growth and influence over the past 40 years. Br J Gen Pract (1992) 0.98

Metabolic disposition of prostacyclin in humans. J Pharmacol Exp Ther (1983) 0.97

Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition. Am Rev Respir Dis (1989) 0.96

The impact of epilepsy surgery on quality of life in children. Neurology (2006) 0.96

Arachidonic acid metabolism in rabbit renal cortex. Formation of two novel dihydroxyeicosatrienoic acids. J Biol Chem (1981) 0.96

Respiratory response to endotoxin and dust predicts evidence of inflammatory response in volunteers in a swine barn. Am J Ind Med (2006) 0.95

8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharmacol (1996) 0.95

Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Anal Biochem (1986) 0.95

Substitution of 15-hydroxyeicosatetraenoic acid in the phosphoinositide signaling pathway. J Biol Chem (1991) 0.94

Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. J Intern Med (2008) 0.94

Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry (1994) 0.93

Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther (1991) 0.93

The growth of carcinogen-induced colon cancer in rats is inhibited by cimetidine. Eur J Surg Oncol (1993) 0.93

Eicosanoids and isoeicosanoids: indices of cellular function and oxidant stress. J Nutr (1998) 0.92

Memory function in childhood epilepsy syndromes. J Paediatr Child Health (2004) 0.92

Clinical and hemodynamic significance of innominate artery lesions evaluated by ultrasonography and digital angiography. Stroke (1988) 0.90

Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man. J Clin Endocrinol Metab (1984) 0.90

Cellular activation by thromboxane A2 and other eicosanoids. Eur Heart J (1993) 0.89

Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol (2000) 0.89

Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation. Br J Clin Pharmacol (1993) 0.89

Aspirin inhibits endogenous prostacyclin and thromboxane biosynthesis in man. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.89

Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha. J Biol Chem (1997) 0.89

Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia. J Clin Pathol (1988) 0.88

Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects. J Pharmacol Exp Ther (1982) 0.87

Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography--negative-ion chemical ionization mass spectrometry. Anal Biochem (1985) 0.86

The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group. Pediatr Infect Dis J (1998) 0.86

Basal transepidermal water loss is increased in platelet-type 12-lipoxygenase deficient mice. J Invest Dermatol (1999) 0.86

Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acid. J Biol Chem (2000) 0.85

Differential effect of 2-aminoethyl-isothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion and endotoxemia. Shock (1998) 0.85

The isoprostanes: a perspective. Prostaglandins (1997) 0.85

Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. Dutch BOA Study Group. J Vasc Surg (2001) 0.84

Intravenous prostacyclin in thrombotic thrombocytopenic purpura. Ann Intern Med (1981) 0.84

An orally active inhibitor of renin. Hypertension (1986) 0.83

The translational therapeutics of prostaglandin inhibition in atherothrombosis. J Thromb Haemost (2009) 0.83

Prevalence of childhood asthma, rhinitis, and eczema in the Ternopil region of Ukraine--results of BUPAS study. Adv Med Sci (2012) 0.82

Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery. J Vasc Surg (2001) 0.81

Glyburide attenuates calmodulin antagonist-stimulated renin release from isolated mouse juxtaglomerular cells. Am J Physiol (1995) 0.81